Linked Life Data

12544986

Source:http://linkedlifedata.com/resource/pubmed/id/12544986

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-1-24
pubmed:abstractText
To assess the cost-effectiveness of drotrecogin alfa (activated) therapy, which was recently shown to reduce mortality in severe sepsis.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0090-3493
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-11
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12544986-Adult, pubmed-meshheading:12544986-Aged, pubmed-meshheading:12544986-Anti-Infective Agents, pubmed-meshheading:12544986-Cost-Benefit Analysis, pubmed-meshheading:12544986-Female, pubmed-meshheading:12544986-Health Care Costs, pubmed-meshheading:12544986-Humans, pubmed-meshheading:12544986-Intensive Care Units, pubmed-meshheading:12544986-Male, pubmed-meshheading:12544986-Middle Aged, pubmed-meshheading:12544986-Models, Econometric, pubmed-meshheading:12544986-Protein C, pubmed-meshheading:12544986-Quality-Adjusted Life Years, pubmed-meshheading:12544986-Recombinant Proteins, pubmed-meshheading:12544986-Risk, pubmed-meshheading:12544986-Sepsis, pubmed-meshheading:12544986-Survival Analysis, pubmed-meshheading:12544986-Treatment Outcome, pubmed-meshheading:12544986-United States
pubmed:year
2003
pubmed:articleTitle
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
pubmed:affiliation
Department of Critical Care Medicine, Clinical Research, Investigation and Systems Modeling of Acute Illness Laboratory, University of Pittsburgh, PA 15213, USA. angusdc@ccm.upmc.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III